Skip to main content
FLO logo

FLO · Flowers Foods Inc

Track FLO — free
$5.60 +0.03 (+0.54%) At close · Oct 5
Market Cap
$1.22B
Shares
212.06M
Volume · Oct 5 7.89M Avg daily vol (3M) 6.55M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$5.60 Open$5.55 Day$5.43–5.62 52W close$5.55–12.90 Avg vol 30d7.9M Short int46.5M · 21.9% float · 5.6d Short vol70% Last earningsAug 21, 2026 DataJan 2020–Oct 2026 Filing10-Q · Aug 20

Up next

Next earnings call
Nov 24, 2026 Est · unconfirmed · in 7 wks
filed Aug 20, 2026
call held Aug 21, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$5.22B
Trailing 12 months
Net income (TTM)
$55.17M
Trailing 12 months
Revenue growth YoY
-4.0%
Year over year
Operating margin
2.7%
Trailing 12 months
P / E (TTM)
22.1
Trailing earnings · reciprocal yield 4.5%
FCF yield
25.1%
TTM · current market cap
Return on invested capital
3.4%
Trailing 12 months
Net cash
−$1.63B
Latest balance sheet
Dividend yield
13.4%
Trailing 12 months
Shares change YoY
+0.2%
Year over year · more shares
Price change (1Y)
-57.2%
Trailing year
Short interest
21.9%
Latest settlement · 5.6 days to cover
View all 115 metrics

AI Brief

Q2 FY27 earnings call · Aug 21, 2026
Q2 FY27

TL;DR. Flowers Foods reported a weak Q2 with sharp profit declines, a 4.0% drop in net sales, and lowered full-year 2026 guidance across net sales, adjusted EBITDA, and adjusted EPS, citing a challenging fresh packaged bread category and rising costs.

Bullish
  • + Pricing/mix improved 1.8% in Q2, partially offsetting volume declines
  • + Q2 cost savings and restructuring actions expected to deliver roughly $20 million tailwind into 2027
Bearish
  • − Net sales declined 4.0% to $1.193 billion with volume down 5.8%
  • − Net income fell 30.3% to $40.7 million and adjusted EPS dropped $0.09 to $0.21
  • − Adjusted EBITDA fell 19.2% to $111.3 million with 180bps margin compression
  • − SD&A rose 160bps as a percentage of net sales on higher workforce, freight, and marketing costs
  • − Full-year 2026 net sales guidance cut to $5.070B-$5.142B from prior $5.163B-$5.267B
  • − Full-year 2026 adjusted EPS guidance cut to $0.75-$0.85 from prior $0.80-$0.90

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Weak Quant / Vol High
Market backdrop VIX 15.5 · calm Equity put/call 0.59
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −34%
below
Price vs 50-day avg −16%
below
RSI (14) 26
oversold
MACD trend Positive
52-week position 1%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −11%
trailing
6-month return −32%
trailing
YTD return −49%
this year
Relative strength −44%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $7 › 200d $8 — 200d above 50d
Institutional flow Accumulating
3 of 454 funds reported for Sep 30 · net +9.5K sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
21.92% of float · ▲ +3.2% MoM · 5.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
454 holders — near 3-yr high, broad support
Squeeze score 69
elevated · 0–100
Fundamentals
Weak
Revenue growth +3%
Y/Y
EPS growth −66%
Y/Y
Free cash flow $319.1M
Balance sheet $976.2M
net debt
Quant / Vol
risk profile
High
Volatility 38%
annualized · 1-yr
Max drawdown −58%
past year
ATR 3.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 2 of last 5
Latest guidance · from the 8-K filed Aug 20, 2026
Net sales · 52-week Fiscal 2026 $5.07B – $5.14B
prior FY $5.26B midpoint −2.9% Y/Y
Adjusted EBITDA · 52-week Fiscal 2026 Non-GAAP $453M – $481M
Depreciation and amortization · 52-week Fiscal 2026 $165M – $170M
Adjusted diluted EPS · 52-week Fiscal 2026 Non-GAAP $0.75 – $0.85
Capital expenditures · 52-week Fiscal 2026 $115M – $125M
Net interest expense · 52-week Fiscal 2026 $65M – $70M
Guided vs delivered · last 5 settled
Sales 52-week Fiscal 2024
guided $5.09B – $5.17B
$5.1B In line
Sales 52-week Fiscal 2023
guided $5.09B – $5.1B
$5.09B In line
Diluted EPS Full Year Fiscal 2023
guided $0.60 – $0.67
$0.58 Miss −8.7%
Sales For the 52-week Fiscal 2022
guided $4.81B – $4.85B
$4.81B Miss −0.5%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−34% Bearish
Price vs 50-day avg
−16% Bearish
RSI (14)
26 Neutral
MACD trend
Positive Bullish
52-week position
1% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $7 › 200d $8 — 200d above 50d
Institutional flow Accumulating
3 of 454 funds reported for Sep 30 · net +9.5K sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
21.92% of float · ▲ +3.2% MoM · 5.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
454 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $6 Now $6 · 1% Range high $13
vs 200-day avg -34% vs 50-day avg -16%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted diluted EPS non-GAAP $0.21 Q2 FY2026 —
Adjusted EBITDA non-GAAP $111.3M Q2 FY2026 —
GAAP → non-GAAP reconciliation
GAAP EBITDA 106.62M
+88K Other pension cost (benefit)
+1.01M Business process improvement costs
+0K Plant closure costs and impairment of assets
+0K Restructuring charges
+5.55M Restructuring-related implementation costs
+0K Acquisition and integration-related costs
+0K Legal settlements and related costs
-1.96M Recovery on inferior ingredients
= Adjusted EBITDA 111.3M
Adjusted EBITDA margin non-GAAP 9.3% Q2 FY2026 —
Adjusted income tax expense non-GAAP 41.35M For the 28-Week Period Ended July 18, 2026 —
Adjusted net income non-GAAP $44.1M Q2 FY2026 —
Adjusted net income per diluted common share non-GAAP $0.49 For the 28-Week Period Ended July 18, 2026 —
Adjusted SD&A non-GAAP 1.08B For the 28-Week Period Ended July 18, 2026 —
Adjusted SD&A percentage of net sales non-GAAP 39.1% Q2 FY2026 —
Capital expenditures $44.5M Q2 FY2026 year-to-date —
Cash flow from operating activities $241.5M Q2 FY2026 year-to-date —
Dividends paid to shareholders $81M Q2 FY2026 year-to-date —
EBITDA 238.1M For the 28-Week Period Ended July 18, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Packaged Foods — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
FLO
Flowers Foods Inc
this stock
$1.22B -48.5% +3.0% — 21.9%
JBS
Jbs N.V.
$38.06B -17.5% — — 1.2%
KHC
Kraft Heinz Co
$28.02B -9.9% -0.1% — 7.9%
GIS
General Mills Inc
$17.99B -31.9% +4.1% — 8.4%
SJM
J M SMUCKER Co
$12.93B +18.8% +3.7% — 4.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
453
% held
104.6%
Reported
3 of 454
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
301
View
Short & Settlement
Short Interest Rising
Shares short
46.5M
Days to cover
5.6d
Change
+1.4M sh
View
Short Volume
Short vol %
70%
As of
Oct 5, 2026
Short Total
View
Fails to Deliver
FTD shares
633.1K
Value
$3.9M
As of
Sep 11, 2026
View
Off-Exchange
Off-exchange %
47.0%
Week of
Aug 31, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Lisa McClain
Amount
$1.0K–$15.0K
Traded
Sep 11, 2025
View
Financials
Financials
Revenue (FY)
$5.3B
Net income (FY)
$83.8M
EPS diluted
$0.40
View
Buybacks
Authorized
shares 67.5M
Remaining
shares 21.3M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 28, 2026
This year
14
View
Proposed Sales
Value
$122.4K
Shares
5.0K
Filed
Jun 22, 2023
View
Earnings & Events
Webcasts
Last webcast
Aug 21, 2026
View

Performance

5D 20D 120D MTD YTD
FLO -0.9% -10.7% -32.2% +0.9% -48.5%
SPY +1.2% +0.6% +11.6% +1.6% +13.6%
vs SPY -2.1% -11.3% -43.8% -0.7% -62.2%

Capital returns

Latest dividend
$0.125 / share · ex Sep 11, 2026
Cut 49.6%
Paid (TTM)
$0.746 / share · 4 payouts
Dividend yield (TTM, derived)
13.32%
Buyback program · as of Jan 3, 2026
Authorized
shares 67.50M
Spent (derived)
shares 46.20M
Remaining
shares 21.30M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1128928 CUSIP 343498101 13F (30d) 10 filings 9 filers Visit website Investor relations